Untreated Perinatal Mood and Anxiety Disorders (PMADs) cost the U.S. economy $14.2 billion annually. In 2026, with medical trends rising by 9.2%, the financial burden on employers and families has reached a critical tipping point. Use this tool to calculate your specific economic risk and the projected return on clinical telehealth intervention.

Household or employee annual compensation.
Based on the Edinburgh Postnatal Depression Scale.
80%
Average out-of-pocket or billed rate in your metro area.

Calculation Summary

Est. 5-Year Societal Impact: $35,910
Employer Productivity Loss: $6,750
Turnover Risk Cost: $7,425
Workdays Regained: 12 days/yr
Potential ROI (Telehealth vs Local): 4.2:1

Based on 2026 ROSE Program benchmarks and CA SB 626 compliance standards.

2026 Economic Benchmarks

Metric Value Source (Adjusted for 2026)
Annual Employer Cost per Affected Employee $6,200 – $7,100 PWC 2026 Medical Cost Trend
New Parent Turnover Cost 150% – 200% Salary U.S. OPM / Inc. 2025
Untreated PMAD Prevalence 20% (1 in 5) CDC Reproductive Health
Telehealth Visit Savings $67 per session Policy Center for MMH

Clinical Intervention Checklist

Ensure your 2026 benefits package meets the latest mental health parity standards.

Expert Strategy Tips

  • Default Benchmarks: If birth rate is unknown, default to 1.5% of total headcount.
  • The "Presenteeism" Trap: For mental health, presenteeism is typically 3x more costly than absenteeism.
  • Preventable Deaths: 84% of pregnancy-related deaths are preventable with intervention before 6 weeks postpartum.